Skip to main content

Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation

Abstract

Objective

Mesenchymal stem cell (MSC) transplantation is a promising therapy for ischemic heart diseases. However, poor cell survival after transplantation greatly limits the therapeutic efficacy of MSCs. The purpose of this study was to investigate the protective effect of angiopoietin-1 (Ang1) preconditioning on MSC survival and subsequent heart function improvement after transplantation.

Methods

MSCs were cultured with or without 50 ng/ml Ang1 in complete medium for 24 h prior to experiments on cell survival and transplantation. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Hoechst staining were applied to evaluate MSC survival after serum deprivation in vitro, while cell survival in vivo was detected by terminal deoxynucleotidyl transferase biotin-dUPT nick end labeling (TUNEL) assay 24 and 72 h after transplantation. Heart function and infarct size were measured four weeks later by small animal echocardiography and Masson’s trichrome staining, respectively.

Results

Ang1 preconditioning induced Akt phosphorylation and increased expression of Bcl-2 and the ratio of Bcl-2/Bax. In comparison with non-preconditioned MSCs, Ang1-preconditioned cell survival was significantly increased while the apoptotic rate decreased in vitro. However, the PI3K/Akt pathway inhibitor, LY294002, abrogated the protective effect of Ang1 preconditioning. After transplantation, the Ang1-preconditioned-MSC group showed a lower death rate, smaller infarct size, and better heart functional recovery compared to the non-preconditioned-MSC group.

Conclusions

Ang1 preconditioning enhances MSC survival, contributing to further improvement of heart function.

This is a preview of subscription content, access via your institution.

References

  • Augustin, H.G., Koh, G.Y., Thurston, G., Alitalo, K., 2009. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol., 10(3):165–177. [doi:10.1038/nrm2639]

    PubMed  Article  CAS  Google Scholar 

  • Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C., et al., 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87(7):1161–1169. [doi:10.1016/ S0092-8674(00)81812-7]

    PubMed  Article  CAS  Google Scholar 

  • Fayard, E., Tintignac, L.A., Baudry, A., Hemmings, B.A., 2005. Protein kinase B/Akt at a glance. J. Cell Sci., 118(Pt 24):5675–5678. [doi:10.1242/jcs.02724]

    PubMed  Article  CAS  Google Scholar 

  • Haider, H., Ashraf, M., 2008. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J. Mol. Cell. Cardiol., 45(4):554–566. [doi:10.1016/j.yjmcc.2008.05.004]

    PubMed  Article  CAS  Google Scholar 

  • Harfouche, R., Hassessian, H.M., Guo, Y., Faivre, V., Srikant, C.B., Yancopoulos, G.D., Hussain, S.N., 2002. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc. Res., 64(1): 135–147. [doi:10.1006/mvre.2002.2421]

    PubMed  Article  CAS  Google Scholar 

  • Kim, I., Kim, H.G., So, J.N., Kim, J.H., Kwak, H.J., Koh, G.Y., 2000. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ. Res., 86(1):24–29. [doi:10. 1161/01.RES.86.1.24]

    PubMed  Article  CAS  Google Scholar 

  • Kontos, C.D., Stauffer, T.P., Yang, W.P., York, J.D., Huang, L., Blanar, M.A., Meyer, T., Peters, K.G., 1998. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol., 18(7):4131–4140.

    PubMed  CAS  Google Scholar 

  • Kwak, H.J., So, J.N., Lee, S.J., Kim, I., Koh, G.Y., 1999. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett., 448(2–3):249–253. [doi:10.1016/S0014-5793(99)00378-6]

    PubMed  Article  CAS  Google Scholar 

  • Leenen, F.H., Huang, B.S., Yu, H., Yuan, B., 1995. Brain ‘ouabain’ mediates sympathetic hyperactivity in congestive heart failure. Circ. Res., 77(5):993–1000. [doi:10.1161/01.RES.77.5.993]

    PubMed  Article  CAS  Google Scholar 

  • Liu, X.B., Jiang, J., Gui, C., Hu, X.Y., Xiang, M.X., Wang, J.A., 2008. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol. Sin., 29(7):815–822. [doi:10.1111/j.1745-7254.2008.00811.x]

    PubMed  Article  Google Scholar 

  • Mangi, A.A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J.S., Dzau, V.J., 2003. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med., 9(9):1195–1201. [doi:10.1038/nm912]

    PubMed  Article  CAS  Google Scholar 

  • Meyer, G.P., Wollert, K.C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., et al., 2006. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113(10):1287–1294. [doi:10.1161/CIRCULATIONAHA.105.575118]

    PubMed  Article  Google Scholar 

  • Oltvai, Z.N., Milliman, C.L., Korsmeyer, S.J., 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74(4): 609–619. [doi:10.1016/0092-8674(93)90509-O]

    PubMed  Article  CAS  Google Scholar 

  • Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., et al., 2001. Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829):701–705. [doi: 10.1038/35070587]

    PubMed  Article  CAS  Google Scholar 

  • Saharinen, P., Bry, M., Alitalo, K., 2010. How do angiopoietins Tie in with vascular endothelial growth factors? Curr. Opin. Hematol., 17(3):198–205. [doi:10.1097/MOH.0b013e3283386673]

    PubMed  CAS  Google Scholar 

  • Shi, L.G., Zhang, G.P., Jin, H.M., 2006. Inhibition of microvascular endothelial cell apoptosis by angiopoietin-1 and the involvement of cytochrome C. Chin. Med. J. (Engl.), 119(9):725–730.

    CAS  Google Scholar 

  • Tang, Y.L., Tang, Y., Zhang, Y.C., Qian, K., Shen, L., Phillips, M.I., 2005. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol., 46(7):1339–1350. [doi:10.1016/j.jacc.2005.05.079]

    PubMed  Article  CAS  Google Scholar 

  • Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., Kessler, P.D., 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105(1):93–98. [doi:10.1161/hc0102.101442]

    PubMed  Article  Google Scholar 

  • Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Sakai, T., Jia, Z.Q., 1999. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation, 100(19 Suppl.):II247–II256. [doi:10.1161/01.CIR.100.suppl_2.II-247]

    PubMed  CAS  Google Scholar 

  • Valable, S., Bellail, A., Lesne, S., Liot, G., Mackenzie, E.T., Vivien, D., Bernaudin, M., Petit, E., 2003. Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis. Faseb. J., 17(3):443–445. [doi:10.1096/fj.02-0372fje]

    PubMed  CAS  Google Scholar 

  • Williams, A.R., Hare, J.M., 2011. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res., 109(8):923–940. [doi:10.1161/CIRCRESAHA.111.243147]

    PubMed  Article  CAS  Google Scholar 

  • Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., et al., 2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429):141–148. [doi:10.1016/S0140-6736(04)16626-9]

    PubMed  Article  Google Scholar 

  • Zeng, H., Li, L., Chen, J.X., 2012. Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts. PLoS One, 7(4):e35905. [doi:10.1371/journal.pone.0035905]

    PubMed  Article  CAS  Google Scholar 

  • Zhu, W., Chen, J., Cong, X., Hu, S., Chen, X., 2006. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells, 24(2):416–425. [doi:10. 1634/stemcells.2005-0121]

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jian-an Wang.

Additional information

The two authors contributed equally to this work

Project supported by the Natural Science Foundation of Zhejiang Province (No. Y2100362) and the Qianjiang Talents Project of Science and Technology Department of Zhejiang Province (No. 2011R10022), China

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liu, Xb., Chen, H., Chen, Hq. et al. Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation. J. Zhejiang Univ. Sci. B 13, 616–623 (2012). https://doi.org/10.1631/jzus.B1201004

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1201004

Key words

  • Mesenchymal stem cells
  • Angiopoietin-1
  • Preconditioning
  • Survival
  • Myocardial infarction

CLC number

  • R541.4